Neurological Disorder Drugs Market is expected to reach a revenue of USD 103.8 Bn by 2033, at 5.1% CAGR: Dimension Market Research [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
With a look at disease modification and collaboration, the landscape will move towards customized therapies, early intervention, and better patient outcomes, providing hope for more effective treatments for neurological conditions.. New York, May 06, 2024 (GLOBE NEWSWIRE) -- Overview The Global Neurological Disorder Drugs Market size is expected to reach USD 66.4 billion by 2024 and is further anticipated to reach USD 103.8 billion by 2033 according to Dimension Market Research. The market is anticipated to register a CAGR of 5.1% from 2024 to 2033. Neurological diseases come from brain or nervous system dysfunction, manifesting in physical or psychological symptoms. Medications like antipsychotics, antiepileptics, anticholinergics, & analgesics are customized to specific conditions to manage symptoms & improve quality of life. Antipsychotics are poised to lead the neurological disorder drugs market in 2024, targeting symptoms of schizophrenia & bipolar disorder by altering brai
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game [Yahoo! Finance]Yahoo! Finance
- Type 1 Diabetes Market Size to Worth USD 24.36 Bn By 2031 [Yahoo! Finance]Yahoo! Finance
- Takeda's dengue vaccine obtains WHO prequalification [Yahoo! Finance]Yahoo! Finance
- Exploring Groupe LDLC Société Anonyme And Two More Top Dividend Stocks On Euronext Paris [Yahoo! Finance]Yahoo! Finance
- WHO approves second vaccine against the mosquito-borne disease dengue as outbreaks intensify [FOX News]FOX News
SNY
Sec Filings
- 5/2/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- SNY's page on the SEC website